Dimesna

双美司那

Report date: 2024/04/23 13:52:27
NME

Base Information

Drug NameDimesna
Drug Alias Name地美司钠DimesnumMesna disulfide双巯乙磺酸钠2，2'-二硫二乙基磺酸二钠 +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutaredoxin modulatorsThioredoxin modulators
TargetsThioredoxinGlutaredoxin
Therapy Area/IndicationsDrug-Related Side Effects and Adverse ReactionsBreast DiseasesNeutropenia +[9] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBulgariaUnited StatesUkraine +[8] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesBionumerik
China Registration ClassN/A

Develop Information

Active CompaniesLantern Pharma IncTakeda Pharmaceutical Co Ltd
Inactive CompaniesBionumerik Pharmaceuticals IncNational Cancer Institute
Active IndicationsCarcinoma, Non-Small-Cell LungAdenocarcinoma of Lung
Inactive IndicationsDrug-Related Side Effects and Adverse ReactionsBreast DiseasesNeutropenia +[7] 

Other Information

ATC CodeN/A
Related LinksN/A